Genetic ablation of NF-κB p50 suppresses the myeloproliferation, demonstrating that NF-κB dysregulation is responsible for the myeloproliferative disease (Zhao et al., 2011). The gene discussed is NFKB1; the disease is myeloproliferative disorder.